MANSFIELD, Mass. -- (BUSINESS WIRE) --

Covidien (NYSE: COV, BSX: COV) will present at the Raymond James 30th Annual Institutional Investors Conference in Orlando, Florida, on March 9, 2009. Charles J. Dockendorff, Executive Vice President and Chief Financial Officer, will discuss the Company in a presentation scheduled to begin at 4:00PM ET.

A live audio webcast of the presentation can be accessed at Covidien's Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

CONTACT:
Covidien
Corporate Communications
Eric Kraus, 508-261-8305
Senior Vice President
eric.kraus@covidien.com
or
Investor Relations
Coleman Lannum, CFA, 508-452-4343
Vice President
cole.lannum@covidien.com
or
Public Relations
Bruce Farmer, 508-452-4372
Vice President
bruce.farmer@covidien.com